Gestational Age-Dependent Increase of Survival Motor Neuron Protein in Umbilical Cord-Derived Mesenchymal Stem Cells.

about

Gestational Age-Dependent Increase of Survival Motor Neuron Protein in Umbilical Cord-Derived Mesenchymal Stem Cells.

Item

http://www.wikidata.org/entity/Q41457078

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Gestational Age-Dependent Incr ...... erived Mesenchymal Stem Cells.

@en

type

Item

label

Gestational Age-Dependent Incr ...... erived Mesenchymal Stem Cells.

@en

prefLabel

Gestational Age-Dependent Incr ...... erived Mesenchymal Stem Cells.

@en

P1476

Gestational Age-Dependent Incr ...... erived Mesenchymal Stem Cells.

@en

P2093

Akemi Shono

http://www.w3.org/2001/XMLSchema#string

Daisuke Kurokawa

http://www.w3.org/2001/XMLSchema#string

Hideto Yamada

http://www.w3.org/2001/XMLSchema#string

Hisahide Nishio

http://www.w3.org/2001/XMLSchema#string

Ichiro Morioka

http://www.w3.org/2001/XMLSchema#string

Kazumoto Iijima

http://www.w3.org/2001/XMLSchema#string

Keiji Yamana

http://www.w3.org/2001/XMLSchema#string

Khin Kyae Mon Thwin

http://www.w3.org/2001/XMLSchema#string

Makiko Yoshida

http://www.w3.org/2001/XMLSchema#string

Mariko Taniguchi-Ikeda

http://www.w3.org/2001/XMLSchema#string

P2860

SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy

Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?

Spinal muscular atrophy: from gene discovery to clinical trials

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells

Phase II open label study of valproic acid in spinal muscular atrophy

Identification and characterization of a spinal muscular atrophy-determining gene

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

Mesenchymal stem cells

P304

194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPED.2017.00194

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sota Iwatani

Dian K Nurputra

Kazumichi Fujioka

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28929094

http://www.w3.org/2001/XMLSchema#string

P932

5591793

http://www.w3.org/2001/XMLSchema#string